Patents by Inventor Gregory G. Mahairas

Gregory G. Mahairas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine adjuvant
    Publication number: 20030162260
    Abstract: The invention features fusion agents such as fusion proteins that are useful for the treatment of and prevention from diseases that are susceptible to the effects of cellular (Th1 type) immune responses. Also encompassed by the invention are nucleic acids encoding the fusion proteins of the invention, vectors containing the nucleic acids, and cells containing the vectors. The invention includes methods of making and using the fusion agents of the invention.
    Type: Application
    Filed: March 10, 2003
    Publication date: August 28, 2003
    Applicant: Iowa State University Research Foundation, Inc., an Iowa corporation
    Inventors: F. Chris Minion, Sreekumar A. Menon, Gregory G. Mahairas
  • Vaccine adjuvant
    Patent number: 6537552
    Abstract: The invention features fusion agents such as fusion proteins that are useful for the treatment of and prevention from diseases that are susceptible to the effects of cellular (Th1 type) immune responses. Also encompassed by the invention are nucleic acids encoding the fusion proteins of the invention, vectors containing the nucleic acids, and cells containing the vectors. The invention includes methods of making and using the fusion agents of the invention.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: March 25, 2003
    Assignee: Iowa State University Research Foundation
    Inventors: F. Chris Minion, Sreekumar A. Menon, Gregory G. Mahairas
  • Virulence-attenuating genetic deletions deleted from mycobacterium BCG
    Patent number: 5700683
    Abstract: The present invention provides specific genetic deletions that result in an avirulent phenotype of a mycobacterium. These deletions may be used as phenotypic markers of providing a means for distinguishing between disease-producing and non-disease producing mycobacteria.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: December 23, 1997
    Assignee: PathoGenesis Corporation
    Inventors: Charles Kendall Stover, Gregory G. Mahairas